These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Growth hormone secretagogue receptor antagonists as anti-obesity therapies? Still an open question. Zhao H, Liu G. Curr Opin Drug Discov Devel; 2006 Jul 01; 9(4):509-15. PubMed ID: 16889233 [Abstract] [Full Text] [Related]
10. Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: side chain exploration. Liu B, Liu M, Xin Z, Zhao H, Serby MD, Kosogof C, Nelson LT, Szczepankiewicz BG, Kaszubska W, Schaefer VG, Falls HD, Lin CW, Collins CA, Sham HL, Liu G. Bioorg Med Chem Lett; 2006 Apr 01; 16(7):1864-8. PubMed ID: 16442284 [Abstract] [Full Text] [Related]
11. Characterization of ghrelin receptor activity in a rat pituitary cell line RC-4B/C. Falls HD, Dayton BD, Fry DG, Ogiela CA, Schaefer VG, Brodjian S, Reilly RM, Collins CA, Kaszubska W. J Mol Endocrinol; 2006 Aug 01; 37(1):51-62. PubMed ID: 16901923 [Abstract] [Full Text] [Related]
14. Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1. Demange L, Boeglin D, Moulin A, Mousseaux D, Ryan J, Bergé G, Gagne D, Heitz A, Perrissoud D, Locatelli V, Torsello A, Galleyrand JC, Fehrentz JA, Martinez J. J Med Chem; 2007 Apr 19; 50(8):1939-57. PubMed ID: 17375904 [Abstract] [Full Text] [Related]
19. Ghrelin control of GH secretion and feeding behaviour: the role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands. Bresciani E, Tamiazzo L, Torsello A, Bulgarelli I, Rapetti D, Caporali S, Perrissoud D, Moulin A, Fehrentz JA, Martinez J, Locatelli V. Eat Weight Disord; 2008 Sep 22; 13(3):e67-74. PubMed ID: 19011367 [Abstract] [Full Text] [Related]